Corrigendum to "Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease" [Neurobiology of Disease, 2024 Jan:190:106376]
Neurobiol Dis. 2024 Apr:193:106444.
doi: 10.1016/j.nbd.2024.106444.
Epub 2024 Feb 24.
1 HD Immune, Vienna, Austria. Electronic address: S.bartl@HDImmune.com.
2 University of Central Florida, Burnett School of Biomedical Sciences, Orlando, FL, United States of America; University of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, Canada.
3 University of Central Florida, Burnett School of Biomedical Sciences, Orlando, FL, United States of America.
4 University of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, Canada.
5 AFFiRiS AG, Vienna, Austria.
6 Centre de recherche du CHU - Universite Laval, Quebec, Canada.
7 University of Central Florida, Burnett School of Biomedical Sciences, Orlando, FL, United States of America. Electronic address: amber.southwell@ucf.edu.